Interesting, page-2295

what would you prefer, the revenue of a single cancer drug company, or an imaging company, that the many cancers will need to use to detect and stage their cancer ?

Smart imaging, early detection.

Lets see, who is going to have a biopsy when MRX gives a non invasive alternative?
And how many biopsies a year could be avoided ?

What about early detection and staging, and monitoring ? When early detection, becomes the standard of care. Its industry adoption, hunger offers low path of resistance.

This is like a monopoly on selling the fuel, to all the cars on the planet.
Anyone else come up with a new smart non radioactive imagining cancer detection down to 10,000 cells, in the last 30-50 years ?